ViewRay Systems, Inc. (VRAYQ)

OTCMKTS · Delayed Price · Currency is USD

0.0001

0.00 (0.00%)

Mar 6, 2026, 9:30 AM EST

9,900% (1Y)

Market Cap	183.00
Revenue (ttm)	105.86M
Net Income (ttm)	-110.42M
Shares Out	183.40M
EPS (ttm)	-0.61
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	25,769
Open	0.0001
Previous Close	0.0001
Day's Range	0.0001 - 0.0001
52-Week Range	n/a
Beta	-23.70
RSI	48.16
Earnings Date	n/a

About ViewRay Systems

ViewRay Systems, Inc. designs, manufactures, and markets magnetic resonance imaging radiation therapy system in the United States and internationally. The company offers MRIdian A3i, an MRI-guided radiation therapy system that provides real-time 3D tissue tracking and automated beam control. Its product is used for the treatment of pancreas, prostate, lung, liver, breast, and oligometastatic cancers. The company was founded in 2004 and is headquartered in Oakwood, Ohio. On July 16, 2023, ViewRay, Inc., along with its affiliate, filed a voluntar... [Read more]

Industry Medical Devices

Sector Healthcare

Founded 2004

Employees 295

Stock Exchange OTCMKTS

Ticker Symbol VRAYQ

Full Company Profile

Financial Performance

In 2022, ViewRay Systems's revenue was $102.21 million, an increase of 45.76% compared to the previous year's $70.12 million. Losses were -$107.33 million, -2.47% less than in 2021.

Financial Statements

News

There is no news available yet.